24. Capturing Metrics for the First Stage of Protocol Review at a Consortium Cancer Center [Abstract] [Poster]
K. Hoy1, A. Firstencel1, H.J. Pounardijian1, J. Chan1, K. Jenkins2, L. Mooney2, M. Kilbane2
1Case Comprehensive Cancer Center; 2Cleveland Clinic Cancer Center
25. Building the NCI Network Program [Abstract]
L. Gaffney, J. Mohr, M. Warren, C. Aghajanian, P. Sabbatini, E. Cottington, L. Deen, B. Zakrzewski, J. Klinger, S. Dominguez, C. Houston
Memorial Sloan Kettering Cancer Center
26. Memorial Sloan Kettering’s Protocol Review Core: A Specialized Approach to Protocol Review Committee Management [Abstract] [Poster]
S. Hanley, J. Migliacci, C. Ryan, X. Lekperic, K. Napolitano, A. Rodavitch
Memorial Sloan Kettering Cancer Center
27. * Time is Money: The Impact of Clinical Research Finance Centralization [Abstract]
C. Sanford, B. Zakrzewski
Memorial Sloan Kettering Cancer Center
28. Utilizing OnCore Capabilities to Automate Annual Continuation Review Submissions to PRMC [Abstract]
S. Phillips
Siteman Cancer Center
29. Building the Post-award Management Infrastructure and Process Support to Reduce Turnaround Time to Collect Study Invoice(s) for Sponsor Clinical Trials [Abstract]
P. Chang
Stanford Cancer Institute
30. Clinical Research: Following the Money [Abstract] [Poster]
C. Golden, A. Annis, L. Hutchins, D. Drum, R. Geary, A. Smith, Z. Feng, N. Pruss
UAMS Winthrop P. Rockefeller Cancer Institute
31. Revising an Institutional PRMC Charter to Achieve NCI Standards: Impacts, Efficiencies, and Potential for Further Improvement [Abstract]
C. Vollmer, N. Kurtzweil, C. Allen, E. Kantemneni, T. Herzog
UC Cancer Center
32. Streamlining Feasibility Assessment Within the Scientific Review Process [Abstract]
A. Anderson, A. Ivey, T. Guinn, T. George
University of Florida Health Cancer Center
33. An Approach to Revitalizing PRMS Scientific Progress Reviews [Abstract] [Poster]
S. Brogan, D. Martinez
Yale Cancer Center, Yale School of Medicine
34. The Sample Collection and Tracking Process for Multisite Investigator-Initiated Trials [Abstract] [Poster]
A. Bauchle, L. Sego
Indiana University Melvin and Bren Simon Cancer Center
35. Stimulating Investigator-Initiated Trial Development: A Comprehensive Approach to Provide Guidance, Mentorship, and Logistical Support for Principal Investigators [Abstract]
A. Anshu, B. Oleson, B. Brito, M. Larson, A. Szabo, K. Marquardt, E. Gore, H. Rui, J. Thomas, B. Shaw, S. Wong
Medical College of Wisconsin Cancer Center
36. A Risk-Based Approach to Monitoring and Auditing Multicenter Investigator-Initiated Trials [Abstract]
K. Muenkel, S. Hughes, J. Walkley, M. Warren, A. Granobles, F. Puma, S. Puleio, K. Yataghene, C. Houston
Memorial Sloan Kettering Cancer Center
37. Increasing Interventional Treatment IITs in the Study Start-up Pipeline With an IIT Committee Approach [Abstract]
N. Kurtzweil, S. Palackdharry, M. Racic, T. Wise-Draper
UC Cancer Center
38. * Investigator-Initiated Trials in the Wild, Wild West: Implementation of the Oncology Clinical Research Support Team at the University of Colorado Cancer Center [Abstract] [Poster] [Digital Presentation]
S. Grolnic, T. Cull
University of Colorado Cancer Center
39. * Redesigning the Delegation of Authority Log for the Modern Cancer Center [Abstract] [Poster]
J. Wurth, T. Presley, J. Feola, A. Vogt, D. Bullock, D. Berkow
Masonic Cancer Center, University of Minnesota
40. MSKCC INDs Multicenter IITs: A Centralized Model in Regulatory Oversight [Abstract] [Poster] [Digital Presentation]
H. Pham, W. Blouin, S. Yoon, J. Walkley, R. Ellis, M. Warren
Memorial Sloan Kettering Cancer Center
41. The Regulatory and Product Development Road to the Future of Cancer Care [Abstract] [Poster]
A. Yadav, R. Ellis, Z. Shabani, D.A. Ho, L. Shrestha, M. Varghese, H. Pham
Memorial Sloan Kettering Cancer Center
42. Electronic Regulatory Binders – A Homegrown System [Abstract] [Poster]
M. Kovak, D. Wade, B. Scanlon, B. Lehman, J. Holley, P. Newman, L. Hutchins, A. Annis
UAMS Winthrop P. Rockefeller Cancer Institute
43. Assessing an ASCO Decision Aid for Improving the Accuracy and Attribution of Serious Adverse Event Reporting From Investigators to Sponsors [Abstract]
L. Byatt1, K. Mileham2, S. Bruinooge3, C. Davis3, E. Garrett-Mayer3, P. Hurley3, L. Levit3, C. Schenkel3, M. Chuk4, A. Buchmeier5, R. Perez6, J. Vose7
1University of New Mexico Comprehensive Cancer Center; 2Levine Cancer Center, Atrium Health; 3American Society of Clinical Oncology; 4U.S. Food and Drug Administration; 5Sarah Cannon Research Institute; 6Bristol Myers Squibb; 7University of Nebraska Medical Center
Back to top
44. Use of REDCap Database to Identify Trends in Non-compliance [Abstract]
A. Kale, N. Cassim
City of Hope Comprehensive Cancer Center
45. The Case for Physician-Led Education Sessions for Research Coordinators [Abstract] [Digital Presentation]
L. Waitkus
Cleveland Clinic Cancer Center
46. Standardized and Personalized Training Results in Increased Job Satisfaction and a Reduction in Turnover [Abstract] [Poster]
K. Jenkins, J. Workman, L. Mooney, M. Kilbane
Cleveland Clinic Cancer Center
47. "Who Cares? It’s Just a Minimal Risk Study": The Case for Research Compliance Oversight of Cancer Population Sciences (CPS) Research [Abstract] [Poster] [Digital Presentation]
E. Beck, K. Thorne
Huntsman Cancer Institute, University of Utah
48. * Development of a Competence-Based Quality Assurance Program [Abstract] [Poster] [Digital Presentation]
R. Kingsford, J. Espinosa, S. Sharry, J. Moehle, L. Lujan, T. Werner
Huntsman Cancer Institute, University of Utah
49. Advising and Trial Guidance for Investigators [Abstract] [Poster]
L. Sego, A. Bauchle, S. Edwards
Indiana University Melvin and Bren Simon Cancer Center
50. New Employee Orientation – Joining the 21st Century [Abstract] [Poster]
F. Kerr, M. Cheviron, S. Edwards, S. Asche
Indiana University Melvin and Bren Simon Cancer Center
51. Training the Masses – Electronic Protocol Training [Abstract] [Poster]
J. Norfleet, F. Kerr, S. Asche, J. Nichols
Indiana University Melvin and Bren Simon Cancer Center
52. Approaching Goals With a Plan: Application of MSK Resources for Internal Audit Process Improvement [Abstract] [Poster]
C. Duarte
Memorial Sloan Kettering Cancer Center
53. Improving Clinical Research Quality and Efficiency Through the Implementation of a Risk-Based Audit Approach [Abstract]
S. Puleio
Memorial Sloan Kettering Cancer Center
54. Expanding the Scope of an Internal Quality Assurance Program to Initiate Change on a Mezzo- and Macro-level [Abstract]
E. Harms, N. Borror, K. Williams
Siteman Cancer Center
55. A Process for the People: Updating Oral Medication Compliance Policy, Guidelines, and Tools [Abstract]
N. Borror, E. Harms, K. Williams, L. Menne
Siteman Cancer Center
56. Protocol-Specific Training in a Commercial IRB World: Adjusting the Process to Ensure Training Keeps Up [Abstract]
L. Menne, E. Harms, N. Borror
Siteman Cancer Center
57. UF Health Cancer Center (UFHCC) Research Fantasy League: A Novel Approach to Employee Engagement [Abstract]
T. Guinn, A. Anderson, A. Ivey, R. Houlihan
University of Florida Health Cancer Center
58. Minimizing Clinical Trial Deviations Through Lean Six Sigma and a CRO Compliance Committee [Abstract]
A. Barkman, T. Cummings, J. Kessler
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
59. Research Staff Orientation and Training [Abstract]
M. Horak, D. Cleary, B. Pappu
UPMC Hillman Cancer Center
60. Development of an Integrated Orientation Program Using the Joint Task Force Core Competencies for Research Professionals [Abstract]
E. Gainey, G. Beals
Vanderbilt-Ingram Cancer Center
61. Let It Go! One Strategy to Maximize Limited QA Resources [Abstract] [Poster]
A. Gateman, E. Smas
Yale Cancer Center, Yale School of Medicine
62. Crack the Walnut! How Community Outreach Research Coordinators Can Empower African American Men to Come Out of Their Shell to Make an Informed Decision About Prostate Cancer Screening, a Cancer Prevention Project [Abstract] [Poster] [Digital Presentation]
C. Chapman, K. Hunt, E. Meisler, D. Allen, S. Abraksia, A. Seals, N. Anderson, K. Sanders
Cleveland Clinic Cancer Center
63. * Completing the Circle: Lay Summary of Protocol Results for Study Participants [Abstract] [Poster]
V. Santana, D. Wallace, D. McGarry, E. Walker, L. Tanner, J. English
Comprehensive Cancer Center, St. Jude Children's Research Hospital
64. A Quick Guide to Affiliate and Satellite Site Activation and Oversight Process [Abstract] [Poster] [Digital Presentation]
G. Nachaegari
Huntsman Cancer Institute, University of Utah
65. The Challenges and Successes of Enrolling Participants on the Tomosynthesis Mammographic Imaging Screening Trial (TMIST or study EA1151) in Hawaii’s Minority/Underserved NCI Community Oncology Research Program (M/U NCORP) [Abstract] [Poster]
S. Cheng1, S. Wakuk1, S. Lieu1, N. Ramos1, K. Bryant-Greenwood1, K. Cassel1, J. Berenberg1, M. Ka’aihue2, R. Lee2, E. Capps2
1University of Hawai'i Cancer Center, University of Hawai'i at Mānoa; 2Queen's Medical Center
66. The Reinvigoration of Alliance Membership and Accrual: From Almost Losing Membership to a High-Performing Site in 2 Years [Abstract]
M. Russell, D. Kitterman, O. Danciu, J. Quigley
University of Illinois Cancer Center
67. Minority Accrual to Therapeutic Clinical Trials [Abstract]
M. Russell, D. Kitterman, O. Danciu
University of Illinois Cancer Center
Back to top
68. * The Road to 90 [Abstract] [Poster]
M. Kelley, K. Donahue, M. Gorno, S. Bigelow, R. Jarrard, P. Dykema, R. George, V. Davis, V. Gorden
Barbara Ann Karmanos Cancer Institute, Wayne State University
69. Sponsor and Collaborator Content Management System [Abstract]
G. Balagot, N. Cassim
City of Hope Comprehensive Cancer Center
70. Redefining Clinical Trial Start-up Through Continuous Improvement [Abstract] [Poster]
A. McCorkle, L. Mooney , M. Kilbane
Cleveland Clinic Cancer Center
71. Improving Study Start-up Timelines: A Comprehensive, Multidisciplinary, Process-Improvement Initiative [Abstract] [Poster]
S. Skendzel, E. Orcholski, D. Krishnadas, R. Nicklow, M. Lindemann, M. Morris, J. Bruan
Masonic Cancer Center, University of Minnesota
72. Enhancing Productivity: Utilizing the ONBASE Application and Pharmacist Created Order Sets to Streamline the Trial Launch Process [Abstract] [Poster]
B. Secor, I. Reveles, D. Yzquierdo, A Rodriguez, M. Nashawati, M. Tomasini, P. Manea
Mays Cancer Center, UT Health San Antonio
73. Clinical Trials Time to Activation: The Process, Structure, and People [Abstract]
Y. Suri, M. El Shayeb
O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham
74. C3OD User Interface – A Simple and Intuitive Solution to Feasibility Analysis for Clinical Trials [Abstract]
D. Pal Mudaranthakam, J. Thompson, D. Streeter
The University of Kansas Cancer Center
75. Time to Activation: Are We Comparing Apples to Apples? [Abstract] [Poster]
A. Skafel, K. Shumate
UCSF Helen Diller Family Comprehensive Cancer Center
76. Reducing Burdens of Site Feasibility Assessments for Conducting Clinical Trials [Abstract] [Poster]
L. Byatt1, P. Hurley2, C. Davis2, J. Hofacker3, E.S. Kim4, D.M. Waterhouse5, G.S. Nowakowski6, D. Kurbegov7
1University of New Mexico Comprehensive Cancer Center; 2American Society of Clinical Oncology; 3Association of American Cancer Institutes; 4Levine Cancer Institute, Atrium Health; 5Oncology Hematology Care, Inc.; 6Mayo Clinic Cancer Center; 7Sarah Cannon Research Institute
77. Automatic Study Cost-Outs: A Tool Designed to Objectively Assess Trial Operations Costs for More Standardized and Efficient Budget Negotiations While Improving Overall Study Time to Activation [Abstract]
J. Plassmeyer, M. Yarkowski, G. Hickman, B. Crocker, K. Richter, K. Yee
UPMC Hillman Cancer Center
Back to top
*Honorable Mention